GGrantIndex
← Search

AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL

$177,135N01FY2022CANIH

Irisys, Inc., San Diego CA

Investigators

Abstract

AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL FOR POSSIBLE CANCER TREATMENT. THE DRUG PRODUCT (DP) WILL BE A 4 MG STRENGTH CAPSULE WHICH IS NOT AVAILABLE

View original record on NIH RePORTER →